Pyrazoloisoquinoline derivatives for inhibiting...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S082000, C546S084000

Reexamination Certificate

active

06841556

ABSTRACT:
Compounds of the formula Iare suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.

REFERENCES:
patent: 4748246 (1988-05-01), Skotnicki et al.
patent: 1134221 (2001-09-01), None
patent: 2185255 (1987-01-01), None
patent: 2185255 (1987-07-01), None
patent: WO 0244153 (2002-06-01), None
patent: WO 03024936 (2003-03-01), None
Lucia Cecchi et al., Synthesis of 1,5-Diaryl-3-Methyl-1 H-pyrazolo[4,5-c] Isoquinolines And Studies of Binding to Specific Peripheral Benzodiazepine Binding Sites, Journal of Pharmaceutical Sciences (1989, pp. 437-442, vol. 78, No. 6).
Yumi Yamamoto et al., Role of the NF-κB Pathway in the Pathogenesis of Human Disease States, Current Molecular Medicine (2001, pp. 287-296, vol. 1).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazoloisoquinoline derivatives for inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazoloisoquinoline derivatives for inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazoloisoquinoline derivatives for inhibiting... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3382901

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.